1,069
Participants
Start Date
September 24, 2019
Primary Completion Date
December 15, 2022
Study Completion Date
April 1, 2025
Pembrolizumab
Pembrolizumab by intravenous (IV) infusion
Gemcitabine
Gemcitabine by IV infusion
Cisplatin
Cisplatin by IV infusion
Placebo
Placebo to pembrolizumab
Taipei Veterans General Hospital ( Site 0861), Taipei,
Koo Foundation Sun Yat-Sen Cancer Center ( Site 0863), Taipei
Chang Gung Medical Foundation. Linkou ( Site 0853), Taoyuan District
National Cheng Kung University Hospital ( Site 0864), Tainan City
Chang Gung Medical Foundation. Kaohsiung Branch ( Site 0865), Kaohsiung City
Auckland City Hospital ( Site 0725), Auckland
Erasme Hospital ( Site 0204), Brussels
Saint-Luc UCL ( Site 0200), Brussels
Liverpool Hospital ( Site 0707), Liverpool
Mid North Coast Cancer Institute ( Site 0708), Port Macquarie
UZA University Hospital Antwerp ( Site 0202), Edegem
UZ Leuven ( Site 0205), Leuven
Western Health-Sunshine Hospital ( Site 0709), St Albans
Eastern Health ( Site 0704), Box Hill
CHU de Liege ( Site 0201), Liège
Gallipoli Medical Research Foundation ( Site 0705), Brisbane
Grand Hopital de Charleroi ( Site 0206), Charleroi
UZ Gent ( Site 0203), Ghent
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0038), New York
Columbia University/Herbert Irving Cancer Center ( Site 0009), New York
National Taiwan University Hospital ( Site 0860), Taipei
Charite - Universtitatsmedizin Berlin CCM ( Site 0269), Berlin
King Chulalongkorn Memorial Hospital ( Site 0884), Bangkok
Ramathibodi Hospital. ( Site 0889), Bangkok
Siriraj Hospital ( Site 0888), Bangkok
Hospital Pulau Pinang ( Site 0773), George Town
Winthrop University Hospital ( Site 0059), Mineola
CHA Bundang Medical Center CHA University ( Site 0835), Seongnam
Seoul National University Bundang Hospital ( Site 0833), Seongnam-si
Ajou University Hospital, Clinical Research Center ( Site 0838), Suwon
ASST Grande Ospedale Metropolitano Niguarda ( Site 0332), Milan
Universitaetsklinikum Hamburg-Eppendorf ( Site 0268), Hamburg
Blue Ridge Cancer Care ( Site 0033), Roanoke
Hospital General Universitario Gregorio Maranon ( Site 0433), Madrid
Hospital Universitario HM Sanchinarro ( Site 0435), Madrid
Hospital Regional Universitario Carlos Haya ( Site 0431), Málaga
Charleston Oncology ( Site 0042), Charleston
Saint Francis Health System ( Site 0051), Greenville
Northwest Georgia Oncology Centers PC ( Site 0045), Marietta
Medizinische Hochschule Hannover ( Site 0265), Hanover
Hospital Universitario General de Asturias ( Site 0434), Oviedo
CHU Bordeaux Haut-Leveque Centre Francois Magendie ( Site 0245), Pessac
Sunpasithiprasong Hospital ( Site 0883), Ubonratchathani
Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 0506), Istanbul
CHU de Montpellier - Hopital Saint-Eloi ( Site 0248), Montpellier
Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 0495), Istanbul
Chungnam National University Hospital ( Site 0840), Daejeon
Centre Eugene Marquis ( Site 0242), Rennes
University of Alabama at Birmingham Comprehensive Cancer Ctr ( Site 0016), Birmingham
Izmir Medical Park Hospital Department of Medical Oncology ( Site 0502), Izmir
Azienda Ospedaliera Universitaria di Verona ( Site 0334), Verona
Erciyes Universitesi Tip Fakultesi ( Site 0500), Kayseri
Universitaetsklinikum Magdeburg A.o.R. ( Site 0271), Magdeburg
Srinagarind Hospital ( Site 0885), Khon Kaen
Policlinico S. Orsola-Malpighi ( Site 0333), Bologna
China Medical University Hospital ( Site 0862), Taichung
Udon Thani Cancer Hospital ( Site 0886), Udon Thani
Kyungpook National University Chilgok Hospital ( Site 0834), Daegu
Inonu Universitesi Medical Fakultesi ( Site 0501), Malatya
Universitaetsklinikum Essen ( Site 0273), Essen
Maharaj Nakorn Chiang Mai Hospital ( Site 0887), Chiang Mai
Hospital Kuala Lumpur ( Site 0768), Kuala Lumpur
Universitaetsklinikum Koeln ( Site 0274), Cologne
Universitaetsklinikum Aachen AOER ( Site 0275), Aachen
Azienda Ospedaliero Universitaria Pisana ( Site 0326), Pisa
Chonnam National University Hwasun Hospital ( Site 0837), Hwasun Gun
University Malaya Medical Centre ( Site 0770), Lembah Pantai
Pantai Hospital Kuala Lumpur ( Site 0771), Kuala Lumpur
Krankenhaus Nordwest ( Site 0266), Frankfurt am Main
Institut Kanser Negara - National Cancer Institute ( Site 0767), Putrajaya
Decatur Memorial Hospital ( Site 0056), Decatur
CHU Clermont-Ferrand - Site Estaing ( Site 0249), Clermont-Ferrand
University of Oklahoma- Stephenson Oklahoma Cancer Center ( Site 0055), Oklahoma City
University of Colorado Hospital ( Site 0011), Aurora
Hospital Sultan Ismail ( Site 0772), Johor Bahru
Klinikum der Ludwig - Maximilian Universitat Munchen ( Site 0264), Munich
Universitaetsklinikum Ulm ( Site 0267), Ulm
UCLA Hematology/Oncology - Santa Monica ( Site 0014), Los Angeles
A.P.H. Paris, Hopital Beaujon ( Site 0247), Clichy
University of California - San Francisco ( Site 0030), San Francisco
Gustave Roussy ( Site 0244), Villejuif
A.O. di Rilievo Nazionale e di alta Specializzazione Garibaldi ( Site 0330), Catania
OHSU Center for Health & Healing ( Site 0044), Portland
Beijing Cancer Hospital ( Site 0138), Beijing
Peking Union Medical College Hospital ( Site 0150), Beijing
The First Hospital of Jilin University ( Site 0131), Changchun
Zhongshan Hospital Fudan University ( Site 0129), Shanghai
Renji Hospital Shanghai Jiaotong University School of Medicine ( Site 0158), Shanghai
Fudan University Shanghai Cancer Center ( Site 0160), Shanghai
The 81st Hospital of PLA ( Site 0128), Nanjing
Anhui Provincial Hospital ( Site 0140), Hefei
Tianjin Medical University Cancer Institute & Hospital ( Site 0155), Tianjin
The First Affiliated Hospital Zhejiang University ( Site 0136), Hangzhou
Zhejiang Cancer Hospital ( Site 0134), Hangzhou
Fujian Provincial Cancer Hospital ( Site 0154), Fuzhou
900 Hospital of the Joint ( Site 0137), Fuzhou
First Affiliated Hospital of The Third Military Medical University ( Site 0130), Chongqing
Hunan Provincial People Hospital ( Site 0142), Changsha
The Third Xiangya Hospital of Central South University ( Site 0157), Changsha
Hunan Cancer Hospital ( Site 0132), Changsha
Guangdong Provincial People s Hospital ( Site 0161), Guangzhou
Harbin Medical University Cancer Hospital ( Site 0133), Harbin
West China Hospital of Sichuan University ( Site 0147), Chengdu
Tangdu Hospital ( Site 0146), Xi’an
The First Affiliated Hospital of Xi an Jiaotong University ( Site 0145), Xi’an
IC La Serena Research ( Site 0630), La Serena
Servicios Medicos Urumed ( Site 0621), Rancagua
Rambam Medical Center ( Site 0308), Haifa
Centro Investigación del Cáncer James Lind ( Site 0622), Temuco
Rabin Medical Center ( Site 0307), Petah Tikva
Sourasky Medical Center ( Site 0306), Tel Aviv
Fundacion Arturo Lopez Perez FALP ( Site 0623), Santiago
Sociedad Oncovida S.A. ( Site 0626), Santiago
Pontificia Universidad Catolica de Chile ( Site 0620), Santiago
Hadassah Ein Karem - Sharett Institute of Oncology ( Site 0309), Jerusalem
University of California San Diego Moores Cancer Center ( Site 0008), La Jolla
Hartford Hospital ( Site 0057), Hartford
Yale University ( Site 0053), New Haven
Winship Cancer Institute of Emory University ( Site 0013), Atlanta
CEMIC ( Site 0581), Buenos Aires
Fundacion Favaloro ( Site 0578), Ciudad de Buenos Aires
Centro Medico San Roque ( Site 0579), San Miguel de Tucumán
Hospital Municipal de Gastroenterologia Dr. Bonorino Udaondo ( Site 0580), CABA
Centro Oncologico Riojano Integral ( Site 0584), La Rioja
Oncobio Servicos de Saude SA ( Site 0604), Nova Lima
Hospital de Caridade de Ijui ( Site 0602), Ijuí
Associacao Hospitalar Moinhos de Vento ( Site 0599), Porto Alegre
Hospital de Clinicas de Porto Alegre ( Site 0610), Porto Alegre
Hospital Nossa Senhora da Conceicao ( Site 0601), Porto Alegre
Instituto COI de Pesquisa Educacao e Gestao ( Site 0606), Rio de Janeiro
Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 0607), São Paulo
Hospital Paulistano - Amil Clinical Research ( Site 0603), São Paulo
Real e Benemerita Associacao Portuguesa de Beneficencia ( Site 0609), São Paulo
A.C. Camargo Cancer Center ( Site 0600), São Paulo
Tom Baker Cancer Centre ( Site 0184), Calgary
Cross Cancer Institute ( Site 0183), Edmonton
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0182), Hamilton
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0180), Montreal
McGill University Health Centre ( Site 0179), Montreal
Staedtisches Klinikum Dresden ( Site 0272), Dresden
Pamela Youde Nethersole Eastern Hospital ( Site 0857), Hong Kong
Prince of Wales Hospital ( Site 0855), Hong Kong
Princess Margaret Hospital. ( Site 0856), Hong Kong
Queen Mary Hospital ( Site 0851), Hong Kong
Queen Elizabeth Hospital. ( Site 0854), Kowloon
Cork University Hospital ( Site 0538), Cork
Bon Secours Hospital ( Site 0526), Cork
Tallaght University Hospital ( Site 0522), Dublin
St Vincents University Hospital ( Site 0521), Dublin
Universita Cattolica del Sacro Cuore - Policlinico Gemelli ( Site 0329), Rome
Policlinico Universitario Campus Biomedico ( Site 0328), Roma
Aichi Cancer Center Hospital ( Site 0080), Nagoya
National Cancer Center Hospital East ( Site 0081), Kashiwa
Kobe City Medical Center General Hospital ( Site 0087), Kobe
Kagawa University Hospital ( Site 0086), Kita-gun
Kanagawa Cancer Center ( Site 0079), Yokohama
Osaka University Hospital ( Site 0085), Suita
Kyorin University Hospital ( Site 0077), Mitaka
National Hospital Organization Kyushu Cancer Center ( Site 0078), Fukuoka
Kyoto University Hospital ( Site 0083), Kyoto
Osaka International Cancer Institute ( Site 0084), Osaka
The Cancer Institute Hospital of JFCR ( Site 0082), Tokyo
Maastricht University Medical Centre ( Site 0347), Maastricht
AMC ( Site 0348), Amsterdam
Erasmus University Medical Center ( Site 0352), Rotterdam
UMCG ( Site 0349), Groningen
Universitair Medisch Centrum Utrecht ( Site 0351), Utrecht
Severance Hospital Yonsei University Health System ( Site 0836), Seoul
Asan Medical Center ( Site 0830), Seoul
Samsung Medical Center ( Site 0831), Seoul
The Catholic University of Korea. Seoul St. Mary s Hospital ( Site 0839), Seoul
Korea University Guro Hospital ( Site 0832), Seoul
Hospital General Universitari Vall d Hebron ( Site 0432), Barcelona
Baskent University Adana Training Hospital ( Site 0499), Adana
Hacettepe University Faculty of Medicine ( Site 0498), Ankara
Abdurrahman Yurtaslan Onkoloji Hastanesi ( Site 0494), Ankara
Gazi Universitesi Tip Fakultesi ( Site 0496), Ankara
Aberdeen Royal Infirmary ( Site 0529), Aberdeen
Royal Free London NHS Foundation Trust ( Site 0520), London
Royal Marsden Hospital ( Site 0536), London
Imperial College Healthcare NHS Trust - Hammersmith Hospital ( Site 0525), London
Royal Marsden NHS Foundation Trust ( Site 0535), Sutton
Belfast City Hospital ( Site 0517), Belfast
University Hospital Coventry and Warwickshire NHS Trust ( Site 0518), Coventry
The Christie NHS Foundation Trust ( Site 0537), Manchester
Merck Sharp & Dohme LLC
INDUSTRY